Key Accounts Director

About reputed company: reputed company. is a biopharmaceutical oncology company with a mission reputed company on improving reputed company of life, increasing potential duration of life, and resolving serious unmet medical needs. At reputed company, we reputed company in building reputed company of world class professionals who are passionate about this mission, and it is our people who reputed company this mission to reality. reputed company’s reputed company values include reputed company, passion for reputed company, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are reputed company in shaping our reputed company toward reputed company. reputed company’s team is inspired to reputed company and help change lives through reputed company’s reputed company studies in the reputed company of oncology. reputed company has multiple global Phase 3 reputed company studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 reputed company study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd reputed company EGFR TKI. - HARMONi-3: Phase 3 reputed company study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 reputed company study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 reputed company study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). reputed company is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Location: reputed company reputed company Los Angeles area reputed company of Role: - The Key Account Director (KAD) is responsible for establishing and maintaining reputed company relationships that reputed company reputed company market reputed company for reputed company’ innovative oncology medicines. - This includes engagement across IDNs, reputed company Centers, regional health systems, and select parent accounts of community provider networks. - These are regionally reputed company positions, with reputed company Key Account Director responsible for a defined geography and corresponding accounts. - The Key Account Director will reputed company and execute reputed company account plans designed to support reputed company product adoption through reputed company reputed company and treatment protocol inclusion, while representing reputed company with key executive decision-makers across key oncology accounts (IDNs, reputed company Centers, regional health systems, and community network parent organizations). - This Market reputed company role also coordinates cross-functional collaboration across reputed company, Medical Affairs, reputed company, and Marketing, to ensure alignment and successful integration of reputed company’s therapies reputed company provider-driven reputed company. Role and Responsibilities: - Translate national reputed company and reputed company strategies into actionable engagement plans across IDNs, reputed company Centers, regional health systems, and select parent accounts of community provider networks. - reputed company account reputed company and execution reputed company on accelerating reputed company reputed company and treatment protocol inclusion post-launch, in reputed company partnership with Medical Affairs, reputed company, Marketing, and reputed company functions. - Establish and maintain business-to-business and C-suite relationships with reputed company key accounts to support educational programs, market reputed company initiatives, and reputed company partnerships. - Build and sustain strong multi-level relationships with reputed company decision-makers, including P&T and formulary committee members, executive pharmacy leadership, C-suite executives, and service line leaders, across key oncology accounts (IDNs, reputed company Centers, regional health systems, and community network parent organizations). - reputed company cross-functional collaboration with reputed company reputed company teams to proactively identify and reputed company reputed company or reimbursement barriers. - reputed company and analyze business opportunities and market dynamics to reputed company reputed company and tactical insights that inform reputed company and reputed company reputed company. - Negotiate favorable reputed company and agreements reputed company with reputed company objectives and market reputed company reputed company. - Champion the voice of the customer internally by sharing insights with reputed company teams, reputed company leadership, and market reputed company stakeholders. - Manage relationships and identify opportunities with select reputed company stakeholders (e.g., NCODA, COA, Oncare reputed company). - reputed company ongoing reputed company feedback and insights to reputed company leadership regarding market dynamics, reputed company reputed company, and account priorities. - reputed company mid- to long-term reputed company engagement plans that support multiple product and indication launches, with a reputed company on building partnerships reputed company transactional contracting. - Facilitate executive exchanges between reputed company leadership and senior executives across IDNs, reputed company Centers, regional health systems, and parent accounts of community provider networks. - Maintain consistent, compliant engagement with reputed company decision-makers, including P&T and formulary committee members, executive pharmacy leadership, C-suite executives, and service line leaders. - Proactively communicate emerging opportunities or risks and mobilize internal resources to address them. - Design and reputed company pull-through initiatives with reputed company reputed company teams to support account execution. - Conduct quarterly business reviews with key accounts and internal stakeholders to monitor reputed company and alignment. - reputed company other duties as assigned Experience, Education and reputed company Knowledge and Skills: - Bachelor’s degree - Minimum of 10+ years of reputed company experience in reputed company account management, market reputed company, or oncology reputed company roles. - Oncology experience - Deep expertise and s trong, established relationships across IDNs, reputed company Centers, regional health systems, and community oncology accounts. - Demonstrated understanding of oncology reimbursement, economic flows, and market dynamics reputed company IDNs, reputed company Centers, GPOs, and community oncology environments. - Exceptional communication and influencing skills, with the ability to engage internal leadership and reputed company executive stakeholders. - reputed company ability to reputed company communicate the reputed company of innovative oncology therapies. - Strong negotiation skills with a reputed company record of achieving reputed company reputed company with reputed company and P&L objectives - Experience supporting pipeline products and oncology product launches. - Demonstrated ability to partner effectively across Medical Affairs, reputed company, and reputed company Reimbursement teams. - Willingness to travel up to 50% for customer meetings, industry conferences, and internal meetings. Preferred Skills: - Advanced degree (MBA, Master’s, PharmD, or PhD). - Deep expertise and understanding of community oncology GPOs and oncology provider networks. - Demonstrated reputed company leading reputed company partnerships and executive engagement initiatives reputed company traditional contracting or rebate arrangements. - Oncology product launch experience reputed company NSCLC. - Prior people leadership experience and ability to help reputed company teams as the organization grows This is the pay for this position Pay Transparency - $205,000 - $240,000 USD - Actual compensation packages are reputed company on several factors that are unique to reputed company candidate, including but not limited to reputed company set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. - The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation. reputed company does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. reputed company employment businesses/agencies are required to contact reputed company’s reputed company at reputed company@smmttx.com to obtain prior written authorization before referring any candidates to reputed company. reputed company. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, reputed company, religion, gender, national reputed company, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Apply To This Job